Single-agent chemotherapy versus combination chemotherapy in advanced non-small cell lung cancer: a quality and meta-analysis study
- 1 August 1995
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 13 (1) , 1-12
- https://doi.org/10.1016/0169-5002(95)00477-i
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- A randomized study of cisplatin versus cisplatin plus vindesine for non-small cell lung carcinomaCancer, 1991
- Chemotherapy in advanced non-small cell lung cancerEuropean Journal of Cancer and Clinical Oncology, 1990
- Further evidence in favour of chemotherapy for inoperable non-small cell lung cancerLung Cancer, 1990
- Continuation of chemotherapy versus supportive care alone in patients with inoperable non-small cell lung cancer and stable disease after two or three cycles of MACC. Results of a randomized prospective studyCancer, 1989
- Combination Chemotherapy with Methotrexate, Adriamycin, Cyclophosphamide and CCNU (MACC) for Nonsmall Cell Lung CancerOncology, 1989
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: A randomized studyEuropean Journal of Cancer and Clinical Oncology, 1984
- Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinomaCancer, 1982
- A method for assessing the quality of a randomized control trialControlled Clinical Trials, 1981